SL Science Holding shows weak fundamental quality (0/9 Piotroski, no moat) and a confirmed falling-knife downtrend (death cross, RSI 39, bearish MACD), and the engine's own asymmetry check models 0% upside even though a resistance-based price target implies 137% upside — a conflict the data does not resolve, keeping the stock flagged for exit.
Thesis pillars
- Weak Quality No Moat→Stable
- Confirmed Falling Knife Downtrend↑Improving
- Upside Estimate Conflict→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 5, 2026· older than 90 days
SL Science Holding Limited (SLBT) Stock Analysis
Healthcare · Biotechnology
Sell if holding. Momentum 4.1/10 is below the 5.0 floor at $1.22 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak overall score: 4.5/10.
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells,... Read more
Sell if holding. Momentum 4.1/10 is below the 5.0 floor at $1.22 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak overall score: 4.5/10. Chart setup: No clear chart pattern; technical signals are mixed. Score 4.5/10, moderate confidence.
Passes 6/9 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
Recent developments
updated Oct 28, 2026Recent Developments — SL Science Holding Limited
Latest news
- NEWS SL Science Holding Limited Reports First Half 2026 Financial Results — fiscal.ai Oct 28, 2026 neutral
- NEWS SL Science Holding H1 Sales $1.387M Up From $1.129M YoY — benzinga Oct 26, 2026 positive
- NEWS 12 Health Care Stocks Moving In Monday's After-Market Session — benzinga Sep 28, 2026 neutral
- NEWS Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday — benzinga Sep 28, 2026 neutral
- NEWS 12 Health Care Stocks Moving In Thursday's Intraday Session — benzinga Sep 10, 2026 neutral
Latest item Oct 28, 2026 · Generated 2026-11-04T12:10:05Z.
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Revenue shrinking — -7.6% YoY. Growth thesis broken unless recovery story develops.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 4.1/10 is below the 5.0 floor at $1.22 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak overall score: 4.5/10. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $1.13. Score 4.5/10, moderate confidence.
Resistance target: $1.71 (+40.2% upside). Prior stop was $1.13. Stop-loss: $1.13.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Weak overall score: 4.5/10; Weak growth.
SL Science Holding Limited trades at a P/E of N/A (forward N/A). TrendMatrix value score: 5.0/10. Verdict: Sell.
What does SL Science Holding Limited do?SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL...
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.